Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention
Published: November 30, 2020
- This scientific statement is intended to raise awareness of the significant adverse cardio-metabolic health-related changes accompanying midlife and the menopause transition (MT).
- New findings on menopause and cardiovascular disease (CVD) risk have emerged since the AHA published Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women 2011 Update; the new information should be considered.
- This statement expands on the 2011 guideline by providing updated, detailed information specific to MT and CVD in women.
Supporting Materials
- Commentary: Menopause Transition and Cardiovascular Health: Time Matters by Licy L. Yanes Cardozo, MD and Damian G. Romero, PhD, FAHA
- Top Things to Know: Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention
- AHA News: Report on latest menopause science looks at heart risks
- News Release: Heart disease risk in women increases leading up to menopause; early intervention is key